The innate antiviral immune system of the cat: Molecular tools for the measurement of its state of activation

Veterinary Immunology and Immunopathology

Volumn 143, Issue 3-4, 2011, Pages 269-281

  Robert Tissot, Céline ^a   Rüegger, Vera L ^a   Cattori, Valentino ^a   Meli, Marina L ^a   Riond, Barbara ^a   Gomes Keller, Maria Alice ^a   Vögtlin, Andrea ^a   Wittig, Burghardt ^b   Juhls, Christiane ^b   Hofmann Lehmann, Regina ^a   Lutz, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MOLOGEN AG   (Germany)

Author keywords

Cat; Immune response modifier; Innate immune system; Real time TaqMan qPCR; Virus

Indexed keywords

ALPHAN3 INTERFERON; BETA INTERFERON; GRANZYME B; INTERLEUKIN 15; INTERLEUKIN 6; PERFORIN; POLYINOSINIC POLYCYTIDYLIC ACID; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CPG ISLAND; DEFENSE MECHANISM; DOWN REGULATION; GENE EXPRESSION; GENE SEQUENCE; HERPES VIRUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKEMIA VIRUS; MALE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN MOTIF; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; CAT DISEASES; CATS; CELL LINE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNITY, INNATE; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERONS; LEUKOCYTES, MONONUCLEAR; MALE; REAL-TIME POLYMERASE CHAIN REACTION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HERPESVIRIDAE; MUS;

EID: 80052365239     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.005     Document Type: Article

References (83)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Baldwin S.L., Powell T.D., Sellins K.S., Radecki S.V., Cohen J.J., Milhausen M.J. The biological effects of five feline IFN-alpha subtypes. Vet Immunol Immunopathol 2004, 99:153-167.
3. Bekisz J., Schmeisser H., Hernandez J., Goldman N.D., Zoon K.C. Human interferons alpha, beta and omega. Growth Factors 2004, 22:243-251.
4. Bracklein T., Theise S., Metzler A., Spiess B.M., Richter M. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells. Am. J. Vet. Res. 2006, 67:1025-1032.
5. Collado V.M., Gomez-Lucia E., Tejerizo G., Miro G., Escolar E., Martin S., Domenech A. Effect of type I interferons on the expression of feline leukaemia virus. Vet Microbiol 2007, 123:180-186.
6. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5:1219-1226.
7. de Mari K., Maynard L., Sanquer A., Lebreux B., Eun H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 2004, 18:477-482.
8. Cunningham M.W., Brown M.A., Shindle D.B., Terrell S.P., Hayes K.A., Ferree B.C., McBride R.T., Blankenship E.L., Jansen D., Citino S.B., Roelke M.E., Kiltie R.A., Troyer J.L., O'Brien S.J. Epizootiology and management of feline leukemia virus in the Florida puma. J. Wildl. Dis. 2008, 44:537-552.
9. Dean G.A., Bernales J.A., Pedersen N.C. Effect of feline immunodeficiency virus on cytokine response to Listeria monocytogenes in vivo. Vet. Immunol. Immunopathol. 1998, 65:125-138.
10. Dean G.A., LaVoy A., Yearley J., Stanton C. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J. Infect. Dis. 2006, 193:1520-1527.
11. Elia A., Laing K.G., Schofield A., Tilleray V.J., Clemens M.J. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 1996, 24:4471-4478.
12. Evermann J.F., Heeney J.L., Roelke M.E., McKeirnan A.J., O'Brien S.J. Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah. Arch. Virol. 1988, 102:155-171.
13. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., Ley T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007, 26:798-811.
14. Foster G.R., Masri S.H., David R., Jones M., Datta A., Lombardi G., Runkell L., de Dios C., Sizing I., James M.J., Marelli-Berg F.M. IFN-alpha subtypes differentially affect human T cell motility. J. Immunol. 2004, 173:1663-1670.
15. Franchini M., Zini E., Osto M., Jablonski K., Kaufmann K., Lutz T.A., Reusch C.E., Ackermann M. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs). Vet. Immunol. Immunopathol. 2010.
16. Genin P., Vaccaro A., Civas A. The role of differential expression of human interferon-a genes in antiviral immunity. Cytokine Growth Factor Rev. 2009, 20:283-295.
17. Gutzwiller M.E., Brachelente C., Taglinger K., Suter M.M., Weissenbock H., Roosje P.J. Feline herpes dermatitis treated with interferon omega. Vet Dermatol 2007, 18:50-54.
18. Haid C., Kaps S., Gonczi E., Hassig M., Metzler A., Spiess B.M., Richter M. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Vet Ophthalmol 2007, 10:278-284.
19. Haller O., Kochs G., Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev. 2007, 18:425-433.
20. Hamerman J.A., Ogasawara K., Lanier L.L. NK cells in innate immunity. Curr. Opin. Immunol. 2005, 17:29-35.
21. Han K.J., Su X., Xu L.G., Bin L.H., Zhang J., Shu H.B. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J. Biol. Chem. 2004, 279:15652-15661.
22. Holzinger D., Jorns C., Stertz S., Boisson-Dupuis S., Thimme R., Weidmann M., Casanova J.L., Haller O., Kochs G. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 2007, 81:7776-7785.
23. Homan E.R., Zendzian R.P., Schott L.D., Levy H.B., Adamson R.H. Studies on poly I:C toxicity in experimental animals. Toxicol. Appl. Pharmacol. 1972, 23:579-588.
24. Horisberger M.A. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 1992, 66:4705-4709.
25. Horisberger M.A., Schrenk R., Staiger S., Leyvraz A.R., Martinod S. Induction of Mx-related protein in cat peripheral blood mononuclear cells after administration of recombinant human interferon hybrid. Antiviral Res. 1990, 13:53-59.
26. Ignacio G., Nordone S., Howard K.E., Dean G.A. Toll-like receptor expression in feline lymphoid tissues. Vet. Immunol. Immunopathol. 2005, 106:229-237.
27. Jiang Z., Zamanian-Daryoush M., Nie H., Silva A.M., Williams B.R., Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 2003, 278:16713-16719.
28. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., Lipford G., Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 2002, 3:499.
29. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2:675-687.
30. Kessler Y., Helfer-Hungerbuehler A.K., Cattori V., Meli M.L., Zellweger B., Ossent P., Riond B., Reusch C.E., Lutz H., Hofmann-Lehmann R. Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues. BMC Mol. Biol. 2009, 10:106.
31. Kipar A., Boretti F.S., Meli M.M., Failing K., Reinacher M., Lutz H. Reduced constitutive cytokine transcription in isolated monocytes of clinically healthy cats, infected with an FIV strain of low pathogenicity. Vet. Immunol. Immunopathol. 2004, 98:215-221.
32. Klein D., Janda P., Steinborn R., Muller M., Salmons B., Gunzburg W.H. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis 1999, 20:291-299.
33. Kochling J., Konig-Merediz S.A., Stripecke R., Buchwald D., Korte A., Von Einsiedel H.G., Sack F., Henze G., Seeger K., Wittig B., Schmidt M. Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides. Clin. Cancer Res. 2003, 9:3142-3149.
34. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., Golenbock D.T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004, 5:190-198.
35. Leutenegger C.M., Klein D., Hofmann-Lehmann R., Mislin C., Hummel U., Boni J., Boretti F., Guenzburg W.H., Lutz H. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J. Virol. Methods 1999, 78:105-116.
36. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 2008, 82:335-345.
37. Loseke S., Grage-Griebenow E., Wagner A., Gehlhar K., Bufe A. Differential expression of IFN-alpha subtypes in human PBMC: evaluation of novel real-time PCR assays. J. Immunol. Methods 2003, 276:207-222.
38. Lv Y., Bao E. Apoptosis induced in chicken embryo fibroblasts in vitro by a polyinosinic:polycytidylic acid copolymer. Toxicol. In Vitro 2009, 23:1360-1364.
39. Martin V., Najbar W., Gueguen S., Grousson D., Eun H.M., Lebreux B., Aubert A. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002, 89:115-127.
40. Meli M.L., Cattori V., Martinez F., Lopez G., Vargas A., Palomares F., Lopez-Bao J.V., Hofmann-Lehmann R., Lutz H. Feline leukemia virus infection: a threat for the survival of the critically endangered Iberian lynx (Lynx pardinus). Vet. Immunol. Immunopathol. 2010, 134:61-67.
41. Meyer T., Stockfleth E. Clinical investigations of Toll-like receptor agonists. Expert Opin. Investig. Drugs 2008, 17:1051-1065.
42. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W., Sedmak D.D. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 1998, 187:675-683.
43. Minagawa T., Ishiwata K., Kajimoto T. Feline interferon-omega treatment on canine parvovirus infection. Vet Microbiol 1999, 69:51-53.
44. Mochizuki M., Nakatani H., Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet Microbiol 1994, 39:145-152.
45. Nagai A., Taira O., Ishikawa M., Hiramatsu K., Hohdatsu T., Koyama H., Arai S., Sato H., Nakano K., Maehara N. Cloning of cDNAs encoding multiple subtypes of feline interferon-alpha from the feline epitherial cell line. J Vet Med Sci 2004, 66:725-728.
46. Nakamura N., Sudo T., Matsuda S., Yanai A. Molecular cloning of feline interferon cDNA by direct expression. Biosci. Biotechnol. Biochem. 1992, 56:211-214.
47. Ohe K., Takahashi T., Hara D., Hara M. Sensitivity of FCV to recombinant feline interferon (rFeIFN). Vet Res Commun 2008, 32:167-174.
48. Paltrinieri S., Crippa A., Comerio T., Angioletti A., Roccabianca P. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration. Vet Immunol Immunopathol 2007, 118:68-74.
49. Pontier D., Fouchet D., Bahi-Jaber N., Poulet H., Guiserix M., Natoli E., Sauvage F. When domestic cat (Felis silvestris catus) population structures interact with their viruses. C. R. Biol. 2009, 332:321-328.
50. Roelke-Parker M.E., Munson L., Packer C., Kock R., Cleaveland S., Carpenter M., O'Brien S.J., Pospischil A., Hofmann-Lehmann R., Lutz H., Mwamengele G.L., Mgasa M.N., Machange G.A., Summers B.A., Appel M.J. A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 1996, 379:441-445.
51. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8:559-568.
52. Sakurai T., Ueda Y., Sato M., Yanai A. Feline interferon production in silkworm by recombinant baculovirus. J Vet Med Sci 1992, 54:563-565.
53. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
54. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
55. Schmidt M., Anton K., Nordhaus C., Junghans C., Wittig B., Worm M. Cytokine and Ig-production by CG-containing sequences with phosphorodiester backbone and dumbbell-shape. Allergy 2006, 61:56-63.
56. Seya T., Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol. Immunother. 2009, 58:1175-1184.
57. Siebeck N., Hurley D.J., Garcia M., Greene C.E., Kostlin R.G., Moore P.A., Dietrich U.M. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. Am J Vet Res 2006, 67:1406-1411.
58. Siren J., Pirhonen J., Julkunen I., Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 2005, 174:1932-1937.
59. Southerden P., Gorrel C. Treatment of a case of refractory feline chronic gingivostomatitis with feline recombinant interferon omega. J Small Anim Pract 2007, 48:104-106.
60. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., Beutler B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U S A 2004, 101:3516-3521.
61. Taglinger K., Van Nguyen N., Helps C.R., Day M.J., Foster A.P. Quantitative real-time RT-PCR measurement of cytokine mRNA expression in the skin of normal cats and cats with allergic skin disease. Vet. Immunol. Immunopathol. 2008, 122:216-230.
62. Taira O., Suzuki M., Takeuchi Y., Aramaki Y., Sakurai I., Watanabe T., Motokawa K., Arai S., Sato H., Maehara N. Expression of feline interferon-alpha subtypes in Esherichia coli, and their antiviral activity and animal species specificity. J Vet Med Sci 2005, 67:543-545.
63. Tanabe T., Shimoda M., Soeno T., Suzuki M., Tajima M., Sato H. Molecular cloning and sequence analysis of feline interferon-stimulated gene 15. Vet. Immunol. Immunopathol. 2008, 126:20-26.
64. Tanabe T., Yamamoto J.K. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma. J Interferon Cytokine Res 2001, 21:1039-1046.
65. Tandon R., Cattori V., Gomes-Keller M.A., Meli M.L., Golder M.C., Lutz H., Hofmann-Lehmann R. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. J. Virol. Methods 2005, 130:124-132.
66. Ueda Y., Sakurai T., Kasama K., Satoh Y., Atsumi K., Hanawa S., Uchino T., Yanai A. Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2',5'-oligoadenylate synthetase activity in the cat. J. Vet. Med. Sci. 1993, 55:1-6.
67. Ueda Y., Sakurai T., Yanai A. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 1993, 55:251-258.
68. Uze G., Schreiber G., Piehler J., Pellegrini S. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 2007, 316:71-95.
69. Vaidya S.A., Cheng G. Toll-like receptors and innate antiviral responses. Curr. Opin. Immunol. 2003, 15:402-407.
70. Van Sant C., Hagglund R., Lopez P., Roizman B. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. U S A 2001, 98:8815-8820.
71. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
72. Vogtlin A., Fraefel C., Albini S., Leutenegger C.M., Schraner E., Spiess B., Lutz H., Ackermann M. Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR. J. Clin. Microbiol. 2002, 40:519-523.
73. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 2004, 34:251-262.
74. Vujanovic L., Szymkowski D.E., Alber S., Watkins S.C., Vujanovic N.L., Butterfield L.H. Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. Blood 2010, 116:575-583.
75. Wagner T.L., Ahonen C.L., Couture A.M., Gibson S.J., Miller R.L., Smith R.M., Reiter M.J., Vasilakos J.P., Tomai M.A. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell. Immunol. 1999, 191:10-19.
76. Weihrauch M.R., Ansen S., Jurkiewicz E., Geisen C., Xia Z., Anderson K.S., Gracien E., Schmidt M., Wittig B., Diehl V., Wolf J., Bohlen H., Nadler L.M. Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer. Clin. Cancer Res. 2005, 11:5993-6001.
77. Weissenbacher S., Riond B., Hofmann-Lehmann R., Lutz H. Evaluation of a novel haematology analyser for use with feline blood. Vet J 2010, 187:381-387.
78. Wittig B., Marten A., Dorbic T., Weineck S., Min H., Niemitz S., Trojaneck B., Flieger D., Kruopis S., Albers A., Loffel J., Neubauer A., Albers P., Muller S., Sauerbruch T., Bieber T., Huhn D., Schmidt-Wolf I.G. Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum. Gene Ther. 2001, 12:267-278.
79. Wonderling R., Powell T., Baldwin S., Morales T., Snyder S., Keiser K., Hunter S., Best E., McDermott M.J., Milhausen M. Cloning, expression, purification, and biological activity of five feline type I interferons. Vet Immunol Immunopathol 2002, 89:13-27.
80. Xue Q., Yang L., Liu X., Liu W. Molecular characterization of feline type I interferon receptor 2. J. Interferon Cytokine Res. 2010, 30:81-88.
81. Yang L.M., Xue Q.H., Sun L., Zhu Y.P., Liu W.J. Cloning and characterization of a novel feline IFN-omega. J Interferon Cytokine Res 2007, 27:119-127.
82. Yoneyama M., Fujita T. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 2010, 20:4-22.
83. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.